Celldex Therapeutics reported $-73.5M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
AbbVie USD 3.61B 2.92B Jun/2026
Agenus USD 39.17M 49.8M Mar/2026
Amgen USD 2.38B 556M Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Celldex Therapeutics USD -73.5M 5.18M Jun/2026
Glaxosmithkline GBP 1.74B 890.94M Mar/2026
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Northwest Biotherapeutics USD -3.4M 23.78M Mar/2026
Pfizer USD -248M 2.94B Jun/2026
Rigel Pharmaceuticals USD 12.42M 13.45M Sep/2024
Roche Holding CHF 6.87B 1.4B Jun/2026